Friday, 16 October 2026European Markets

ELECTROMAGNET GEO Stock Bullish By 13% At Session Start On Thursday

Loading stream...

(VIANEWS) - Shares of ELECTROMAGNET GEO (Oslo Børs Benchmark Index_GI: EMGS.OL) rose by a staggering 13.07% to kr3.20 at 10:24 EST on Thursday, after three sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI is falling 0.38% to kr1,238.81, after two consecutive sessions in a row of losses. This seems, up to now, a somewhat down trend exchanging session today.

About ELECTROMAGNET GEO

Electromagnetic Geoservices ASA, together with its subsidiaries, provides electromagnetic (EM) surveying services to the offshore oil and gas exploration industry. It is involved in the planning, acquisition, processing, modelling, interpretation, and integration of EM data. The company uses its patented EM survey method to find hydrocarbons in offshore reservoirs. It engages in the provision of controlled-source EM surveying and magneto telluric surveying; imaging and interpretation; rental of software and cluster; and training services. The company has operations in Europe, the Middle East, Africa, Norway, North and South America, Asia, and the Pacific Ocean. Electromagnetic Geoservices ASA was incorporated in 2002 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, ELECTROMAGNET GEO has a trailing twelve months EPS of kr-1.492.

Volume

Today's last reported volume for ELECTROMAGNET GEO is 1169252 which is 37.08% above its average volume of 852953.

Volatility

ELECTROMAGNET GEO's last week, last month's, and last quarter's current intraday variation average was a negative 3.96%, a negative 0.35%, and a positive 3.90%.

ELECTROMAGNET GEO's highest amplitude of average volatility was 3.96% (last week), 4.00% (last month), and 3.90% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ELECTROMAGNET GEO's stock is considered to be overbought (>=80).

More news about ELECTROMAGNET GEO (EMGS.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com